CADILA HEALTHCARE
Updated
READY FOR NEXT SPRINT, SUBMITTED DATA OF TRIALS TO GOVERNMENT AND CROSSING RECENT HIGHEST CLOSING WITH VOLUMES. NEWS OF VACCINE APPROVAL IN NEXT WEEK MAY BE. TARGET IS UNCHARTED.
KEEP SUPPORT AT 630, FOR POSITIONAL VIEW.
KEEP SUPPORT AT 630, FOR POSITIONAL VIEW.
Note
Stoploss Hit
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.